Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells

Hepatology

Volumn 28, Issue 4 I, 1998, Pages 1110-1116

  Schmidt, Warren N ^a,b,c   Wu, Ping ^a   Brashear, Donna ^a   Klinzman, Donna ^b   Phillips, Mary Jeanne Perino ^a   Labrecque, Douglas R ^a,b   Stapleton, Jack T ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TIME FACTORS;

EID: 0031704926     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280428     Document Type: Article

References (25)

1. Choo QL, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. Isolation of a cDNA derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
2. Bradley D. Virology, molecular biology, and serology of hepatitis C virus. Transfusion Med Rev 1992;5:93-102.
3. Cuthbert JA. Hepatitis C: progress and problems. Clin Microbiol Rev 1994;7:505-532.
4. Read A, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto I, Zeldis J, et al. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 1991;114:282-284.
5. El-Ashmawy L, Hassanein T, Gavaler J, Van Thiel D. Prevalence of hepatitis C virus antibody in a liver transplantation population. Dig Dis Sci 1992;37:1110-1115.
6. Hoofnagle JH. Treatment of HCV. In: Zuckerman AJ, Thomas HC, eds. Viral Hepatitis. New York: Churchill Livingstone, 1993;303-312.
7. Hoofnagle JH, Di Bisceglie AM, Shindo M. Antiviral therapy of hepatitis C - present and future. HEPATOLOGY 1993;17:130-136.
8. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, et al. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. HEPATOLOGY 1993;18:1319-1325.
9. Tsubota A, Chayama K, Ikeda Y, Yasuji A, Koida I, Saitoh S, Hashimoto M, et al. Factors predictive of response to interferon-therapy in hepatitis C virus infection. HEPATOLOGY 1994;19:1088-1094.
10. Serfaty L, Giral P, Loria A, Andreani T, Legendre C, Poupon R. Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol 1994;21:12-17.
11. Davis GL and Lau JYN. Factors predictive of a beneficial response to therapy of hepatitis C. HEPATOLOGY 1997;26(suppl 1):122S-127S.
12. Lindsay K. Therapy of hepatitis C: overview. HEPATOLOGY 1997;26(suppl 1):71S-77S.
13. Gretch D. Diagnostic tests for hepatitis C. HEPATOLOGY 1997;26(suppl 1):43S-47S.
14. Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon. HEPATOLOGY 1992;15:1013-1016.
15. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, Fusamoto H, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. HEPATOLOGY 1992;15:37-41.
16. Garson JA, Brillanti S, Ring C, Perini P, Miglioli M, Barbara L. Hepatitis C viraemia rebound after "successful" interferon therapy in patients with chronic non-A, non-B hepatitis. J Med Virol 1992;37:210-214.
17. Schmidt WN, Wu P, Han JQ, Perino MJ, LaBrecque DR, Stapleton JT. Distribution of hepatitis C virus (HCV) in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. J Infect Dis 1997:176:20-26.
18. Bouffard P, Hayashi P, Acevedo R, Levy N, Zeldis J. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992;166:1276-1280.
19. Gil B, Qian C, Riezu Boj J, Civeira MP, Prieto J. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. HEPATOLOGY 1993;18:1050-1054.
20. Lanford RE, Chavez D, Chisari FV, Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol 1995;69:8079-8083.
21. Laskus T, Radkowski M, Wang LF, Cianciara J, Vargas H, Rakela J. Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: a case against extrahepatic replication. J Gen Virol 1997;78:2747-2750.
22. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trepo C, Inchauspe G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996;97:845-851.
23. Hawkins A, Davidson G, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay and an in-house limiting dilution method. J Clin Microbiol 1997;35:187-192.
24. Nolte FS. Laboratory diagnosis of Hepatitis C. Immunol Invest 1997;26:199-207.
25. Schmidt W, Klinzman D, LaBrecque D, Macfarlane D, Stapleton J. Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells. J Med Virol 1995;47:153-160.